We showed that oral administration of plant GlcCer to APP transgenic mice markedly reduced Aβ levels and amyloid plaques and eventually attenuated Aβ-related pathologies, such as inflammation, synaptic dysfunction and cognitive deficits. Here, APP is linked to Cognitive impairment.